CA2524929C - Cryoconservation de cellules souches humaines derivees de blastocystes au moyen d'un procede de vitrification dans des paillettes fermees - Google Patents

Cryoconservation de cellules souches humaines derivees de blastocystes au moyen d'un procede de vitrification dans des paillettes fermees Download PDF

Info

Publication number: CA2524929C
Authority: CA; Canada
Prior art keywords: cells; solution; hbs; cell; feeder
Prior art date: 2003-05-08
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

CA2524929A

Other languages

English (en)

Other versions

CA2524929A1 (fr

Inventor

Anita Sjoegren

Eva Karin Kilmare

Sven Enerbaeck

Peter Eriksson

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Takara Bio Europe AB

Original Assignee

Cellartis AB

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-05-08

Filing date

2004-05-10

Publication date

2015-01-13

2004-05-10 Application filed by Cellartis AB filed Critical Cellartis AB

2004-11-18 Publication of CA2524929A1 publication Critical patent/CA2524929A1/fr

2015-01-13 Application granted granted Critical

2015-01-13 Publication of CA2524929C publication Critical patent/CA2524929C/fr

2024-05-10 Anticipated expiration legal-status Critical

Status Expired - Fee Related legal-status Critical Current

Links

238000000034 method Methods 0.000 title claims abstract description 147
239000010902 straw Substances 0.000 title claims abstract description 110
210000002459 blastocyst Anatomy 0.000 title claims abstract description 73
238000004017 vitrification Methods 0.000 title claims abstract description 54
210000000130 stem cell Anatomy 0.000 title claims abstract description 51
241000282414 Homo sapiens Species 0.000 title claims description 81
238000005138 cryopreservation Methods 0.000 title description 12
210000004027 cell Anatomy 0.000 claims abstract description 526
238000012546 transfer Methods 0.000 claims abstract description 24
238000011534 incubation Methods 0.000 claims abstract description 22
238000007789 sealing Methods 0.000 claims abstract description 10
239000000243 solution Substances 0.000 claims description 123
IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 50
HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims description 42
HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims description 42
239000002577 cryoprotective agent Substances 0.000 claims description 41
HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims description 40
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 24
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 24
238000004031 devitrification Methods 0.000 claims description 20
229930006000 Sucrose Natural products 0.000 claims description 16
239000005720 sucrose Substances 0.000 claims description 16
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 14
229920002674 hyaluronan Polymers 0.000 claims description 12
239000000203 mixture Substances 0.000 claims description 12
238000010899 nucleation Methods 0.000 claims description 12
239000004034 viscosity adjusting agent Substances 0.000 claims description 10
229920001917 Ficoll Polymers 0.000 claims description 9
238000005406 washing Methods 0.000 claims description 9
KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 7
229960003160 hyaluronic acid Drugs 0.000 claims description 7
108010010803 Gelatin Proteins 0.000 claims description 5
229920000159 gelatin Polymers 0.000 claims description 5
239000008273 gelatin Substances 0.000 claims description 5
235000019322 gelatine Nutrition 0.000 claims description 5
235000011852 gelatine desserts Nutrition 0.000 claims description 5
ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims description 4
-1 Percoll Polymers 0.000 claims description 3
108010088751 Albumins Proteins 0.000 claims description 2
102000009027 Albumins Human genes 0.000 claims description 2
239000007864 aqueous solution Substances 0.000 claims description 2
229920000036 polyvinylpyrrolidone Polymers 0.000 claims description 2
239000001267 polyvinylpyrrolidone Substances 0.000 claims description 2
235000013855 polyvinylpyrrolidone Nutrition 0.000 claims description 2
125000000185 sucrose group Chemical group 0.000 claims description 2
125000000647 trehalose group Chemical group 0.000 claims description 2
239000000783 alginic acid Substances 0.000 claims 1
235000010443 alginic acid Nutrition 0.000 claims 1
229920000615 alginic acid Polymers 0.000 claims 1
229960001126 alginic acid Drugs 0.000 claims 1
150000004781 alginic acids Chemical class 0.000 claims 1
235000011187 glycerol Nutrition 0.000 claims 1
239000002609 medium Substances 0.000 description 60
210000000287 oocyte Anatomy 0.000 description 41
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 34
238000010257 thawing Methods 0.000 description 34
241000699666 Mus <mouse, genus> Species 0.000 description 26
239000011521 glass Substances 0.000 description 23
230000000694 effects Effects 0.000 description 22
239000007788 liquid Substances 0.000 description 22
238000010494 dissociation reaction Methods 0.000 description 20
230000005593 dissociations Effects 0.000 description 20
238000007710 freezing Methods 0.000 description 20
230000008014 freezing Effects 0.000 description 20
108010017842 Telomerase Proteins 0.000 description 18
238000011084 recovery Methods 0.000 description 18
229910052757 nitrogen Inorganic materials 0.000 description 17
102000002260 Alkaline Phosphatase Human genes 0.000 description 15
108020004774 Alkaline Phosphatase Proteins 0.000 description 15
206010043276 Teratoma Diseases 0.000 description 14
238000004458 analytical method Methods 0.000 description 14
241000699670 Mus sp. Species 0.000 description 13
238000005520 cutting process Methods 0.000 description 13
230000004069 differentiation Effects 0.000 description 13
230000012010 growth Effects 0.000 description 13
239000000463 material Substances 0.000 description 13
230000000644 propagated effect Effects 0.000 description 13
238000000338 in vitro Methods 0.000 description 12
238000001727 in vivo Methods 0.000 description 12
UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 12
210000001519 tissue Anatomy 0.000 description 12
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
239000006144 Dulbecco’s modiﬁed Eagle's medium Substances 0.000 description 11
206010028980 Neoplasm Diseases 0.000 description 11
239000012620 biological material Substances 0.000 description 11
230000015572 biosynthetic process Effects 0.000 description 11
238000012258 culturing Methods 0.000 description 11
238000003752 polymerase chain reaction Methods 0.000 description 11
102000029816 Collagenase Human genes 0.000 description 10
108060005980 Collagenase Proteins 0.000 description 10
108090000379 Fibroblast growth factor 2 Proteins 0.000 description 10
102000003974 Fibroblast growth factor 2 Human genes 0.000 description 10
102100035423 POU domain, class 5, transcription factor 1 Human genes 0.000 description 10
101710126211 POU domain, class 5, transcription factor 1 Proteins 0.000 description 10
210000000349 chromosome Anatomy 0.000 description 10
229960002424 collagenase Drugs 0.000 description 10
210000001654 germ layer Anatomy 0.000 description 10
230000035755 proliferation Effects 0.000 description 10
108090000623 proteins and genes Proteins 0.000 description 10
230000002255 enzymatic effect Effects 0.000 description 9
238000002360 preparation method Methods 0.000 description 9
230000008569 process Effects 0.000 description 9
102000004169 proteins and genes Human genes 0.000 description 9
LAQPKDLYOBZWBT-NYLDSJSYSA-N (2s,4s,5r,6r)-5-acetamido-2-{[(2s,3r,4s,5s,6r)-2-{[(2r,3r,4r,5r)-5-acetamido-1,2-dihydroxy-6-oxo-4-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}hexan-3-yl]oxy}-3,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy}-4-hydroxy-6-[(1r,2r)-1,2,3-trihydrox Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]([C@@H](NC(C)=O)C=O)[C@@H]([C@H](O)CO)O[C@H]1[C@H](O)[C@@H](O[C@]2(O[C@H]([C@H](NC(C)=O)[C@@H](O)C2)[C@H](O)[C@H](O)CO)C(O)=O)[C@@H](O)[C@@H](CO)O1 LAQPKDLYOBZWBT-NYLDSJSYSA-N 0.000 description 8
102000004190 Enzymes Human genes 0.000 description 8
108090000790 Enzymes Proteins 0.000 description 8
NWIBSHFKIJFRCO-WUDYKRTCSA-N Mytomycin Chemical compound C1N2C(C(C(C)=C(N)C3=O)=O)=C3[C@@H](COC(N)=O)[C@@]2(OC)[C@@H]2[C@H]1N2 NWIBSHFKIJFRCO-WUDYKRTCSA-N 0.000 description 8
229930182555 Penicillin Natural products 0.000 description 8
JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 8
229940088598 enzyme Drugs 0.000 description 8
238000009396 hybridization Methods 0.000 description 8
229940049954 penicillin Drugs 0.000 description 8
238000010186 staining Methods 0.000 description 8
ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 7
229930182816 L-glutamine Natural products 0.000 description 7
239000000470 constituent Substances 0.000 description 7
238000011109 contamination Methods 0.000 description 7
238000002224 dissection Methods 0.000 description 7
238000007747 plating Methods 0.000 description 7
210000002966 serum Anatomy 0.000 description 7
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
241001465754 Metazoa Species 0.000 description 6
239000006285 cell suspension Substances 0.000 description 6
238000012512 characterization method Methods 0.000 description 6
210000001671 embryonic stem cell Anatomy 0.000 description 6
239000003797 essential amino acid Substances 0.000 description 6
235000020776 essential amino acid Nutrition 0.000 description 6
238000003757 reverse transcription PCR Methods 0.000 description 6
229960005322 streptomycin Drugs 0.000 description 6
210000004340 zona pellucida Anatomy 0.000 description 6
108020004414 DNA Proteins 0.000 description 5
238000002965 ELISA Methods 0.000 description 5
108010059712 Pronase Proteins 0.000 description 5
210000005056 cell body Anatomy 0.000 description 5
238000005119 centrifugation Methods 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 5
210000003981 ectoderm Anatomy 0.000 description 5
210000001900 endoderm Anatomy 0.000 description 5
238000011156 evaluation Methods 0.000 description 5
238000002474 experimental method Methods 0.000 description 5
KIUKXJAPPMFGSW-MNSSHETKSA-N hyaluronan Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H](C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-MNSSHETKSA-N 0.000 description 5
229940099552 hyaluronan Drugs 0.000 description 5
210000003734 kidney Anatomy 0.000 description 5
210000003716 mesoderm Anatomy 0.000 description 5
230000000394 mitotic effect Effects 0.000 description 5
239000000523 sample Substances 0.000 description 5
238000003860 storage Methods 0.000 description 5
238000012360 testing method Methods 0.000 description 5
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 4
108091003079 Bovine Serum Albumin Proteins 0.000 description 4
239000012981 Hank's balanced salt solution Substances 0.000 description 4
QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
238000003556 assay Methods 0.000 description 4
150000001720 carbohydrates Chemical class 0.000 description 4
235000014633 carbohydrates Nutrition 0.000 description 4
238000006243 chemical reaction Methods 0.000 description 4
238000001514 detection method Methods 0.000 description 4
230000004720 fertilization Effects 0.000 description 4
210000002950 fibroblast Anatomy 0.000 description 4
239000012634 fragment Substances 0.000 description 4
239000010410 layer Substances 0.000 description 4
230000007774 longterm Effects 0.000 description 4
239000011159 matrix material Substances 0.000 description 4
229960004857 mitomycin Drugs 0.000 description 4
210000004940 nucleus Anatomy 0.000 description 4
BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 4
239000000047 product Substances 0.000 description 4
102000005962 receptors Human genes 0.000 description 4
108020003175 receptors Proteins 0.000 description 4
230000004083 survival effect Effects 0.000 description 4
NNJPGOLRFBJNIW-HNNXBMFYSA-N (-)-demecolcine Chemical compound C1=C(OC)C(=O)C=C2[C@@H](NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-HNNXBMFYSA-N 0.000 description 3
FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 description 3
SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 3
229920001287 Chondroitin sulfate Polymers 0.000 description 3
NNJPGOLRFBJNIW-UHFFFAOYSA-N Demecolcine Natural products C1=C(OC)C(=O)C=C2C(NC)CCC3=CC(OC)=C(OC)C(OC)=C3C2=C1 NNJPGOLRFBJNIW-UHFFFAOYSA-N 0.000 description 3
108010037362 Extracellular Matrix Proteins Proteins 0.000 description 3
102000010834 Extracellular Matrix Proteins Human genes 0.000 description 3
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
108010076876 Keratins Proteins 0.000 description 3
102000011782 Keratins Human genes 0.000 description 3
241000283973 Oryctolagus cuniculus Species 0.000 description 3
DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
239000013543 active substance Substances 0.000 description 3
238000000137 annealing Methods 0.000 description 3
239000000872 buffer Substances 0.000 description 3
239000002775 capsule Substances 0.000 description 3
229940059329 chondroitin sulfate Drugs 0.000 description 3
230000002759 chromosomal effect Effects 0.000 description 3
238000001816 cooling Methods 0.000 description 3
239000013078 crystal Substances 0.000 description 3
238000004925 denaturation Methods 0.000 description 3
230000036425 denaturation Effects 0.000 description 3
150000002016 disaccharides Chemical class 0.000 description 3
210000002242 embryoid body Anatomy 0.000 description 3
238000011049 filling Methods 0.000 description 3
239000012595 freezing medium Substances 0.000 description 3
230000003993 interaction Effects 0.000 description 3
238000004519 manufacturing process Methods 0.000 description 3
230000031864 metaphase Effects 0.000 description 3
229920003023 plastic Polymers 0.000 description 3
239000004033 plastic Substances 0.000 description 3
238000004321 preservation Methods 0.000 description 3
230000000717 retained effect Effects 0.000 description 3
210000001988 somatic stem cell Anatomy 0.000 description 3
210000001550 testis Anatomy 0.000 description 3
108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
241000282693 Cercopithecidae Species 0.000 description 2
229920000742 Cotton Polymers 0.000 description 2
241000699800 Cricetinae Species 0.000 description 2
238000000116 DAPI staining Methods 0.000 description 2
102100036912 Desmin Human genes 0.000 description 2
108010044052 Desmin Proteins 0.000 description 2
102100023374 Forkhead box protein M1 Human genes 0.000 description 2
ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 2
101000907578 Homo sapiens Forkhead box protein M1 Proteins 0.000 description 2
206010061598 Immunodeficiency Diseases 0.000 description 2
102000035195 Peptidases Human genes 0.000 description 2
108091005804 Peptidases Proteins 0.000 description 2
ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
239000004365 Protease Substances 0.000 description 2
238000011530 RNeasy Mini Kit Methods 0.000 description 2
241000700159 Rattus Species 0.000 description 2
238000011579 SCID mouse model Methods 0.000 description 2
108010006785 Taq Polymerase Proteins 0.000 description 2
239000013504 Triton X-100 Substances 0.000 description 2
229920004890 Triton X-100 Polymers 0.000 description 2
108090000631 Trypsin Proteins 0.000 description 2
102000004142 Trypsin Human genes 0.000 description 2
229960000583 acetic acid Drugs 0.000 description 2
230000004071 biological effect Effects 0.000 description 2
230000000903 blocking effect Effects 0.000 description 2
238000010805 cDNA synthesis kit Methods 0.000 description 2
210000000845 cartilage Anatomy 0.000 description 2
230000021164 cell adhesion Effects 0.000 description 2
230000005779 cell damage Effects 0.000 description 2
230000008859 change Effects 0.000 description 2
230000000052 comparative effect Effects 0.000 description 2
230000001143 conditioned effect Effects 0.000 description 2
230000003750 conditioning effect Effects 0.000 description 2
210000005045 desmin Anatomy 0.000 description 2
238000011161 development Methods 0.000 description 2
239000003792 electrolyte Substances 0.000 description 2
210000002257 embryonic structure Anatomy 0.000 description 2
210000002744 extracellular matrix Anatomy 0.000 description 2
239000012091 fetal bovine serum Substances 0.000 description 2
239000012894 fetal calf serum Substances 0.000 description 2
MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 description 2
238000007429 general method Methods 0.000 description 2
239000012362 glacial acetic acid Substances 0.000 description 2
230000001744 histochemical effect Effects 0.000 description 2
238000003384 imaging method Methods 0.000 description 2
238000002513 implantation Methods 0.000 description 2
238000007901 in situ hybridization Methods 0.000 description 2
238000002347 injection Methods 0.000 description 2
239000007924 injection Substances 0.000 description 2
108010044426 integrins Proteins 0.000 description 2
102000006495 integrins Human genes 0.000 description 2
231100000053 low toxicity Toxicity 0.000 description 2
210000001161 mammalian embryo Anatomy 0.000 description 2
239000012528 membrane Substances 0.000 description 2
239000003147 molecular marker Substances 0.000 description 2
230000000877 morphologic effect Effects 0.000 description 2
231100000252 nontoxic Toxicity 0.000 description 2
230000003000 nontoxic effect Effects 0.000 description 2
230000003204 osmotic effect Effects 0.000 description 2
239000012188 paraffin wax Substances 0.000 description 2
229910052697 platinum Inorganic materials 0.000 description 2
229920001296 polysiloxane Polymers 0.000 description 2
210000003765 sex chromosome Anatomy 0.000 description 2
238000010561 standard procedure Methods 0.000 description 2
239000011550 stock solution Substances 0.000 description 2
239000000126 substance Substances 0.000 description 2
239000004094 surface-active agent Substances 0.000 description 2
239000012588 trypsin Substances 0.000 description 2
230000035899 viability Effects 0.000 description 2
IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 1
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
KBTLDMSFADPKFJ-UHFFFAOYSA-N 2-phenyl-1H-indole-3,4-dicarboximidamide Chemical compound N1C2=CC=CC(C(N)=N)=C2C(C(=N)N)=C1C1=CC=CC=C1 KBTLDMSFADPKFJ-UHFFFAOYSA-N 0.000 description 1
208000037068 Abnormal Karyotype Diseases 0.000 description 1
102000007469 Actins Human genes 0.000 description 1
108010085238 Actins Proteins 0.000 description 1
HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 1
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
241000283690 Bos taurus Species 0.000 description 1
102100032912 CD44 antigen Human genes 0.000 description 1
241000283707 Capra Species 0.000 description 1
108010001857 Cell Surface Receptors Proteins 0.000 description 1
102000000844 Cell Surface Receptors Human genes 0.000 description 1
206010008805 Chromosomal abnormalities Diseases 0.000 description 1
208000031404 Chromosome Aberrations Diseases 0.000 description 1
102000009268 Collagen Receptors Human genes 0.000 description 1
108010048623 Collagen Receptors Proteins 0.000 description 1
102000004266 Collagen Type IV Human genes 0.000 description 1
108010042086 Collagen Type IV Proteins 0.000 description 1
108010017826 DNA Polymerase I Proteins 0.000 description 1
102000004594 DNA Polymerase I Human genes 0.000 description 1
206010013457 Dissociation Diseases 0.000 description 1
238000008157 ELISA kit Methods 0.000 description 1
241000283086 Equidae Species 0.000 description 1
108700039887 Essential Genes Proteins 0.000 description 1
OTMSDBZUPAUEDD-UHFFFAOYSA-N Ethane Chemical compound CC OTMSDBZUPAUEDD-UHFFFAOYSA-N 0.000 description 1
238000002738 Giemsa staining Methods 0.000 description 1
102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
229920002683 Glycosaminoglycan Polymers 0.000 description 1
108060003393 Granulin Proteins 0.000 description 1
102100033636 Histone H3.2 Human genes 0.000 description 1
108010033040 Histones Proteins 0.000 description 1
241000282412 Homo Species 0.000 description 1
101000868273 Homo sapiens CD44 antigen Proteins 0.000 description 1
101000984015 Homo sapiens Cadherin-1 Proteins 0.000 description 1
101001052035 Homo sapiens Fibroblast growth factor 2 Proteins 0.000 description 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
102100025323 Integrin alpha-1 Human genes 0.000 description 1
108010041341 Integrin alpha1 Proteins 0.000 description 1
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
206010068052 Mosaicism Diseases 0.000 description 1
229920002274 Nalgene Polymers 0.000 description 1
102000002584 Octamer Transcription Factor-3 Human genes 0.000 description 1
108010068425 Octamer Transcription Factor-3 Proteins 0.000 description 1
229930040373 Paraformaldehyde Natural products 0.000 description 1
241001494479 Pecora Species 0.000 description 1
241000577979 Peromyscus spicilegus Species 0.000 description 1
238000002123 RNA extraction Methods 0.000 description 1
238000010240 RT-PCR analysis Methods 0.000 description 1
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
241000282887 Suidae Species 0.000 description 1
210000001744 T-lymphocyte Anatomy 0.000 description 1
XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical compound ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 description 1
241000607479 Yersinia pestis Species 0.000 description 1
FKAWLXNLHHIHLA-YCBIHMBMSA-N [(2r,3r,5r,7r,8s,9s)-2-[(1s,3s,4s,5r,6r,7e,9e,11e,13z)-14-cyano-3,5-dihydroxy-1-methoxy-4,6,8,9,13-pentamethyltetradeca-7,9,11,13-tetraenyl]-9-[(e)-3-[2-[(2s)-4-[[(2s,3s,4s)-4-(dimethylamino)-2,3-dihydroxy-5-methoxypentanoyl]amino]butan-2-yl]-1,3-oxazol-4 Chemical compound O1C([C@@H](C)CCNC(=O)[C@@H](O)[C@@H](O)[C@H](COC)N(C)C)=NC(\C=C\C[C@H]2[C@H]([C@H](O)C[C@]3(O2)C([C@@H](OP(O)(O)=O)[C@@H]([C@H](C[C@H](O)[C@H](C)[C@H](O)[C@H](C)\C=C(/C)\C(\C)=C\C=C\C(\C)=C/C#N)OC)O3)(C)C)C)=C1 FKAWLXNLHHIHLA-YCBIHMBMSA-N 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
230000004913 activation Effects 0.000 description 1
230000001464 adherent effect Effects 0.000 description 1
239000011543 agarose gel Substances 0.000 description 1
238000000246 agarose gel electrophoresis Methods 0.000 description 1
230000004075 alteration Effects 0.000 description 1
238000010171 animal model Methods 0.000 description 1
230000000692 anti-sense effect Effects 0.000 description 1
239000000427 antigen Substances 0.000 description 1
108091007433 antigens Proteins 0.000 description 1
102000036639 antigens Human genes 0.000 description 1
238000013459 approach Methods 0.000 description 1
239000012298 atmosphere Substances 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000008901 benefit Effects 0.000 description 1
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
210000000988 bone and bone Anatomy 0.000 description 1
210000001185 bone marrow Anatomy 0.000 description 1
210000004958 brain cell Anatomy 0.000 description 1
238000010804 cDNA synthesis Methods 0.000 description 1
210000004413 cardiac myocyte Anatomy 0.000 description 1
238000004113 cell culture Methods 0.000 description 1
239000006143 cell culture medium Substances 0.000 description 1
230000032823 cell division Effects 0.000 description 1
230000010261 cell growth Effects 0.000 description 1
210000000170 cell membrane Anatomy 0.000 description 1
210000003855 cell nucleus Anatomy 0.000 description 1
230000004663 cell proliferation Effects 0.000 description 1
230000003833 cell viability Effects 0.000 description 1
108091092328 cellular RNA Proteins 0.000 description 1
230000001413 cellular effect Effects 0.000 description 1
239000003153 chemical reaction reagent Substances 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
239000002299 complementary DNA Substances 0.000 description 1
238000012790 confirmation Methods 0.000 description 1
210000004748 cultured cell Anatomy 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
230000001066 destructive effect Effects 0.000 description 1
229960001760 dimethyl sulfoxide Drugs 0.000 description 1
208000018459 dissociative disease Diseases 0.000 description 1
238000009826 distribution Methods 0.000 description 1
238000005516 engineering process Methods 0.000 description 1
210000002615 epidermis Anatomy 0.000 description 1
210000000981 epithelium Anatomy 0.000 description 1
238000011067 equilibration Methods 0.000 description 1
230000003203 everyday effect Effects 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
239000000834 fixative Substances 0.000 description 1
239000012530 fluid Substances 0.000 description 1
210000001035 gastrointestinal tract Anatomy 0.000 description 1
238000001502 gel electrophoresis Methods 0.000 description 1
230000004077 genetic alteration Effects 0.000 description 1
210000004602 germ cell Anatomy 0.000 description 1
108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
239000001963 growth medium Substances 0.000 description 1
210000002064 heart cell Anatomy 0.000 description 1
239000001307 helium Substances 0.000 description 1
229910052734 helium Inorganic materials 0.000 description 1
SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
SAMYCKUDTNLASP-UHFFFAOYSA-N hexane-2,2-diol Chemical compound CCCCC(C)(O)O SAMYCKUDTNLASP-UHFFFAOYSA-N 0.000 description 1
102000047933 human CDH1 Human genes 0.000 description 1
210000004408 hybridoma Anatomy 0.000 description 1
239000001257 hydrogen Substances 0.000 description 1
229910052739 hydrogen Inorganic materials 0.000 description 1
230000006910 ice nucleation Effects 0.000 description 1
238000010191 image analysis Methods 0.000 description 1
230000002055 immunohistochemical effect Effects 0.000 description 1
238000012151 immunohistochemical method Methods 0.000 description 1
238000011532 immunohistochemical staining Methods 0.000 description 1
238000010324 immunological assay Methods 0.000 description 1
230000036046 immunoreaction Effects 0.000 description 1
230000002779 inactivation Effects 0.000 description 1
208000015181 infectious disease Diseases 0.000 description 1
210000000936 intestine Anatomy 0.000 description 1
238000002955 isolation Methods 0.000 description 1
239000008101 lactose Substances 0.000 description 1
238000011031 large-scale manufacturing process Methods 0.000 description 1
231100001231 less toxic Toxicity 0.000 description 1
239000004973 liquid crystal related substance Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
244000144972 livestock Species 0.000 description 1
238000012423 maintenance Methods 0.000 description 1
230000014759 maintenance of location Effects 0.000 description 1
230000001404 mediated effect Effects 0.000 description 1
108020004999 messenger RNA Proteins 0.000 description 1
238000000386 microscopy Methods 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
230000011278 mitosis Effects 0.000 description 1
238000012544 monitoring process Methods 0.000 description 1
230000004899 motility Effects 0.000 description 1
239000012120 mounting media Substances 0.000 description 1
210000003205 muscle Anatomy 0.000 description 1
239000013642 negative control Substances 0.000 description 1
230000001537 neural effect Effects 0.000 description 1
210000001020 neural plate Anatomy 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
229920002866 paraformaldehyde Polymers 0.000 description 1
239000008188 pellet Substances 0.000 description 1
150000003904 phospholipids Chemical class 0.000 description 1
239000013641 positive control Substances 0.000 description 1
230000008092 positive effect Effects 0.000 description 1
230000002980 postoperative effect Effects 0.000 description 1
230000002062 proliferating effect Effects 0.000 description 1
230000002035 prolonged effect Effects 0.000 description 1
239000001294 propane Substances 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
230000024155 regulation of cell adhesion Effects 0.000 description 1
230000001105 regulatory effect Effects 0.000 description 1
238000011160 research Methods 0.000 description 1
238000012827 research and development Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
150000003839 salts Chemical class 0.000 description 1
238000013341 scale-up Methods 0.000 description 1
230000003248 secreting effect Effects 0.000 description 1
230000035939 shock Effects 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000010703 silicon Substances 0.000 description 1
239000002356 single layer Substances 0.000 description 1
210000004927 skin cell Anatomy 0.000 description 1
238000007711 solidification Methods 0.000 description 1
230000008023 solidification Effects 0.000 description 1
239000002904 solvent Substances 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
239000007858 starting material Substances 0.000 description 1
210000003699 striated muscle Anatomy 0.000 description 1
239000000758 substrate Substances 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
239000013589 supplement Substances 0.000 description 1
238000004114 suspension culture Methods 0.000 description 1
MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical compound [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
230000007704 transition Effects 0.000 description 1
230000000472 traumatic effect Effects 0.000 description 1
210000004291 uterus Anatomy 0.000 description 1
238000011179 visual inspection Methods 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0618—Cells of the nervous system
- C12N5/0623—Stem cells
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61D—VETERINARY INSTRUMENTS, IMPLEMENTS, TOOLS, OR METHODS
- A61D19/00—Instruments or methods for reproduction or fertilisation
- A61D19/04—Instruments or methods for reproduction or fertilisation for embryo transplantation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/02—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from embryonic cells
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/52—Fibronectin; Laminin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Environmental Sciences (AREA)
Dentistry (AREA)
Veterinary Medicine (AREA)
Cell Biology (AREA)
General Engineering & Computer Science (AREA)
Developmental Biology & Embryology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Transplantation (AREA)
Reproductive Health (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

CA2524929A 2003-05-08 2004-05-10 Cryoconservation de cellules souches humaines derivees de blastocystes au moyen d'un procede de vitrification dans des paillettes fermees Expired - Fee Related CA2524929C (fr)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
US46932003P	2003-05-08	2003-05-08
DKPA200300700		2003-05-08
DKPA200300700		2003-05-08
US60/469,320		2003-05-08
DKPA200300984		2003-06-27
DKPA200300983		2003-06-27
DKPA200300984		2003-06-27
DKPA200300983		2003-06-27
PCT/EP2004/005031 WO2004098285A2 (fr)	2003-05-08	2004-05-10	Cryoconservation de cellules souches humaines derivees de blastocystes au moyen d'un procede de vitrification dans des paillettes fermees

Publications (2)

Publication Number	Publication Date
CA2524929A1 CA2524929A1 (fr)	2004-11-18
CA2524929C true CA2524929C (fr)	2015-01-13

Family

ID=33437113

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA2524929A Expired - Fee Related CA2524929C (fr)	2003-05-08	2004-05-10	Cryoconservation de cellules souches humaines derivees de blastocystes au moyen d'un procede de vitrification dans des paillettes fermees

Country Status (9)

Country	Link
EP (1)	EP1624751A2 (fr)
JP (1)	JP2006525006A (fr)
KR (1)	KR20060032953A (fr)
AU (1)	AU2004237425B2 (fr)
CA (1)	CA2524929C (fr)
GB (1)	GB2417961B8 (fr)
IL (1)	IL171595A (fr)
SE (1)	SE0502397L (fr)
WO (1)	WO2004098285A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005072790A1 (fr)	2004-02-02	2005-08-11	I.M.T. Interface Multigrad Technology Ltd.	Dispositif de refroidissement directionnel de matiere biologique
EP1711053A2 (fr)	2004-02-02	2006-10-18	I.M.T. Interface Multigrad Technology Ltd.	Materiau biologique et procedes et solutions de conservation de celui-ci
JP2008501320A (ja)	2004-06-02	2008-01-24	イーエス・セル・インターナショナル・プライヴェート・リミテッド	細胞保存方法
US7892726B2 (en)	2004-06-07	2011-02-22	Core Dynamics Limited	Method for sterilizing lyophilized eukaryotic anuclear cells with gamma irradiation
US8037696B2 (en)	2004-08-12	2011-10-18	Core Dynamics Limited	Method and apparatus for freezing or thawing of a biological material
MY142987A (en)	2005-06-08	2011-02-14	Hayashibara Biochem Lab	Solution for tissue adhesion prevention and method for tissue adhesion prevention
US8198085B2 (en)	2005-08-03	2012-06-12	Core Dynamics Limited	Somatic cells for use in cell therapy
WO2008006605A2 (fr)	2006-07-13	2008-01-17	Cellartis Ab	Nouvelle population de cellules précurseurs cardiaques multipotentes dérivées de cellules souches dérivées de blastocystes humains
WO2008011070A2 (fr) *	2006-07-19	2008-01-24	Reprocure, Llc	Procédé de cryoconservation des oocytes comprenant le perçage de la zone pellucide avant la vitrification
US8785193B2 (en)	2006-09-14	2014-07-22	The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services	Dissection tool and methods of use
JP2010534065A (ja)	2007-07-20	2010-11-04	セルアーティスアーベー	ヒト胚盤胞幹細胞に、胚体内胚葉（ＤＥ‐ｈｅｐ）を介して由来する新規な肝細胞の集団
DK2209888T3 (da)	2007-10-12	2020-01-20	Astellas Inst For Regenerative Medicine	Forbedrede fremgangsmåder til fremstilling af rpe-celler og sammensætninger af rpe-celler
EP2156735A1 (fr) *	2008-08-13	2010-02-24	Dr. H. Zech GmbH	Procédé et instrument de vitrification et stockage de spécimen biologique
US8956867B2 (en)	2008-11-07	2015-02-17	Wisconsin Alumni Research Foundation	Method for culturing stem cells
AU2011247984B2 (en) *	2010-05-07	2015-04-30	University Of North Carolina At Chapel Hill	Method of engrafting cells from solid tissues
KR101358973B1 (ko) *	2010-11-24	2014-02-11	중앙대학교 산학협력단	트리할로오스를 이용한 정원줄기세포의 동결보존 방법
US8961956B2 (en)	2011-11-30	2015-02-24	Ocata Therapeutics, Inc.	Mesenchymal stromal cells and uses related thereto
SI2785359T1 (sl)	2011-11-30	2018-11-30	Astellas Institute For Regenerative Medicine	Mezenhimske stromalne celice in uporabe povezane z njimi
HK1208054A1 (en)	2012-07-12	2016-02-19	爱姆斯坦生物技术公司	Mesenchymal-like stem cells derived from human embryonic stem cells, methods and uses thereof
KR101509295B1 (ko) *	2012-11-07	2015-04-07	경상대학교산학협력단	스트로우 내벽에 배아를 부착하는 부착성 스트로우 유리화 동결법
BR102016003292B1 (pt)	2015-07-14	2022-08-09	Genus Plc	Método para preparar embrião de ungulado produzido in vitro, dispositivo e métodos de congelamento e descongelamento de embriões de ungulado
US10531657B2 (en)	2015-12-07	2020-01-14	Coopersurgical, Inc.	Low temperature specimen carriers and related methods
CN110214776A (zh) *	2019-07-01	2019-09-10	安徽农业大学	一种基于麦管冷冻Tip载体的猪囊胚的冻存和解冻方法
AU2021267900A1 (en)	2020-05-08	2023-01-19	Gallant Pet Inc.	Uterine-derived regenerative cell compositions and uses thereof
CN120458084B (zh) *	2025-07-09	2025-09-26	山东奥克斯畜牧种业有限公司	一种牛玻璃化冷冻体外胚胎的解冻液及其使用方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999011121A1 (fr) *	1997-09-03	1999-03-11	Danish Institute Of Agricultural Sciences	Procede et auxiliaires pour cryopreservation d'un materiau biologique tel que des cellules d'oeufs
DE69913186T3 (de) *	1998-10-14	2012-08-09	Katrina T. Forest	Verfahren zur verglasung einer biologischen probe
US6875607B1 (en) *	1998-11-09	2005-04-05	Es Cell International Pte Ltd	Embryonic stem cells
EP1131998A1 (fr) *	2000-03-08	2001-09-12	Director-General Of National Institute Of Animal Industry, Ministry Of Agriculture, Forestry And Fisheries	Procédé de cryoconservation de cellules

2004
- 2004-05-10 JP JP2006505414A patent/JP2006525006A/ja active Pending
- 2004-05-10 CA CA2524929A patent/CA2524929C/fr not_active Expired - Fee Related
- 2004-05-10 AU AU2004237425A patent/AU2004237425B2/en not_active Ceased
- 2004-05-10 EP EP04731935A patent/EP1624751A2/fr not_active Withdrawn
- 2004-05-10 KR KR1020057020730A patent/KR20060032953A/ko not_active Withdrawn
- 2004-05-10 GB GB0525046A patent/GB2417961B8/en not_active Expired - Fee Related
- 2004-05-10 WO PCT/EP2004/005031 patent/WO2004098285A2/fr not_active Ceased
2005
- 2005-10-27 IL IL171595A patent/IL171595A/en not_active IP Right Cessation
- 2005-10-28 SE SE0502397A patent/SE0502397L/sv not_active Application Discontinuation

Also Published As

Publication number	Publication date
GB2417961B8 (en)	2008-05-09
GB0525046D0 (en)	2006-01-18
CA2524929A1 (fr)	2004-11-18
GB2417961A8 (en)	2008-05-09
GB2417961A (en)	2006-03-15
AU2004237425B2 (en)	2010-03-04
KR20060032953A (ko)	2006-04-18
JP2006525006A (ja)	2006-11-09
IL171595A (en)	2012-07-31
WO2004098285A2 (fr)	2004-11-18
GB2417961B (en)	2008-03-12
SE0502397L (sv)	2005-12-29
EP1624751A2 (fr)	2006-02-15
WO2004098285A3 (fr)	2005-01-06
AU2004237425A1 (en)	2004-11-18

Legal Events

Date	Code	Title	Description
2009-01-29	EEER	Examination request
2017-06-21	MKLA	Lapsed	Effective date: 20170510

Publication	Publication Date	Title
CA2524929C (fr)	2015-01-13	Cryoconservation de cellules souches humaines derivees de blastocystes au moyen d'un procede de vitrification dans des paillettes fermees
US20090093054A1 (en)	2009-04-09	Cryopreservation of human blastocyst-derived stem cells by use of a closed straw vitrification method
Ji et al.	2004	Cryopreservation of adherent human embryonic stem cells
US20100183566A1 (en)	2010-07-22	METHOD FOR EFFICIENT TRANSFER OF HUMAN BLASTOCYST-DERIVED STEM CELLS (hBS CELLS) FROM A FEEDER-SUPPORTED TO A FEEDER-FREE CULTURE SYSTEM
Vaags et al.	2009	Derivation and characterization of canine embryonic stem cell lines with in vitro and in vivo differentiation potential
US20050095703A1 (en)	2005-05-05	Method for the establishment of a pluripotent human blastocyst - derived stem cell line
KR20180079302A (ko)	2018-07-10	시원 생식 세포를 기능적으로 성숙한 난모 세포로 분화시키는 배양 방법
JP2002529070A (ja)	2002-09-10	胚性幹細胞
AU785428B2 (en)	2007-05-17	Human embryonic stem cells derived from frozen-thawed embryo
US20070020608A1 (en)	2007-01-25	Method for the generation of neural progenitor cells
KR20080036549A (ko)	2008-04-28	포유류 배아 유래의 줄기 세포 또는 줄기 세포 유사 세포의제조 방법
JP4689175B2 (ja)	2011-05-25	毛包を再生するための組成物、方法及び再生された毛包を担持する動物
CN1784143B (zh)	2012-06-27	通过使用闭合吸管玻璃化方法低温贮藏人胚泡来源的干细胞
CN101497873A (zh)	2009-08-05	通过使用闭合吸管玻璃化方法低温贮藏人胚泡来源的干细胞
Quadri	2023	VETERINARY GYNAECOLOGY AND OBSTETRICS
TOUFIKI	2022	PHYSIOLOGICAL EFFECT OF CRYOPROTECTANTS IN FREEZING OF EMBRYONIC FIBROBLAST CELLS
Amporn et al.	2021	Review Sources of pluripotent stem cells for production of transgenic animals in mammals and poultry.
Muhammad Alahdal	2011	Deriving bovine embryonic stem-like cells in defined conditions
Moon et al.	2008	Efficiency of equilibrium and vitrification solution of mesenchymal stem cells obtained from human amnion
Cillo	2007	Porcine embryonic stem cells: Facts, challenges and hopes
Nel-Themaat	2006	Gamete and cell technologies for use in biological resource banking
Lam	2013	Derivation of Stem Cells from in vivo Produced Goat Embryos
MXPA99008933A (es)	2000-02-02	Linea de celulas germinales embrionicas, humanas y metodos de uso